Discovery of drugs that possess activity against feline leukemia virus
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
1989 • 1,195 citations
Tenofovir Disoproxil Fumarate
2004 • 437 citations
Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- R -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA
1998 • 316 citations
Mutations Associated with Failure of Raltegravir Treatment Affect Integrase Sensitivity to the Inhibitor In Vitro
2008 • 281 citations
A Transmissible Virus-Induced Lymphocytic Leukemia of the Cat<xref ref-type="fn" rid="FN2">2</xref>
1969 • 194 citations
Understanding Ribonucleotide Reductase Inactivation by Gemcitabine
2007 • 143 citations
The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.
1992 • 142 citations
3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.
1987 • 137 citations
Correlation between Humoral Antibody and Regression of Tumours induced by Feline Sarcoma Virus
1971 • 111 citations
Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy
2010 • 89 citations
Inhibition of Xenotropic Murine Leukemia Virus-Related Virus by APOBEC3 Proteins and Antiviral Drugs
2010 • 84 citations
Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome
2010 • 56 citations
Mechanism of Inactivation of Human Ribonucleotide Reductase with p53R2 by Gemcitabine 5′-Diphosphate
2009 • 49 citations
An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
2010 • 43 citations
Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir
2009 • 38 citations
Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors
2010 • 36 citations
The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome
2008 • 34 citations
Reduced dNTP Binding Affinity of 3TC-resistant M184I HIV-1 Reverse Transcriptase Variants Responsible for Viral Infection Failure in Macrophage
2008 • 30 citations
Comparison of DNA polymerase activities between recombinant feline immunodeficiency and leukemia virus reverse transcriptases
2005 • 29 citations
YADD Mutants of Human Immunodeficiency Virus Type 1 and Moloney Murine Leukemia Virus Reverse Transcriptase Are Resistant to Lamivudine Triphosphate (3TCTP) In Vitro
2001 • 27 citations
Epidemiological studies on feline leukaemia virus infection. I. A serological survey in urban cats
1975 • 25 citations
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells
2010 • 24 citations
Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine
2011 • 22 citations
Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir
2011 • 18 citations
Zidovudine toxicity to cats infected with feline leukemia virus
1990 • 16 citations
Treatment of feline leukemia virus-infected cats with paramunity inducer
1998 • 11 citations
Lymphocyte T-Cell Immunomodulator (LTCI): Review of the Immunopharmacology of a New Veterinary Biologic
2008 • 9 citations